| |
 Grace
Hsiao, DMD, is the Director of Inpatient Dental Consult Services
at the Brigham and Women's Hospital (BWH) in Boston, MA. She is
also the assistant director of the BWH - Harvard-Wide General
Practice Residency in hospital dentistry and an instructor at
the Harvard School of Dental Medicine (HSDM). Dr. Hsiao's primary
research involves mucositis clinical trials. In addition, she
conducts oral mucositis assessment trainings for various nation-wide
clinical trials in chemo- and radiotherapy-induced mucositis.
Clinically, Dr. Hsiao is a general dentist specializing in the
care of medically-compromised and special needs patients at the
BWH and Dana-Farber Cancer Institute. Dr. Hsiao received her BA
from the University of California, Berkeley in the field of neurobiology
and psychology. She received her DMD from the Harvard School of
Dental Medicine (HSDM) and completed a general practice residency
in hospital dentistry at the University of Washington, Seattle.
 Stephen
T. Sonis, DMD, DMSc, received his dental degree from Tufts in
1972, and entered a combined doctorate and clinical specialty-training
program at Harvard. Following completion of his doctoral degree
and clinical programs in Oral Medicine and Periodontology, Dr.
Sonis was awarded a Knox Fellowship to study at Oxford with Ian
MacLennan. In 1977, he returned to the United States to accept
joint positions at the Peter Bent Brigham Hospital, Sidney Farber
Cancer Center and the Harvard School of Dental Medicine. His research
activities focused on laboratory investigation of lymphocyte-neutrophil
interactions and the initiation of descriptive clinical studies
on the oral complications of cancer therapy. In 1978, following
the consolidation of three of Harvard's teaching hospitals, Dr.
Sonis was appointed the division chief at Brigham and Women's
Hospital. His research converged to focus on the biology and clinical
significance of cancer regimen-related mucosal toxicities. Currently,
Dr. Sonis is the Chief of the Division of Oral Medicine, Oral
and Maxillofacial Surgery and Dentistry at the Dana-Farber Cancer
Institute, Senior Surgeon at Brigham and Women's Hospital, and
Professor and Chair of the Department of Oral Medicine, Infection
and Immunity at Harvard. Many of his former students and residents
now hold academic and clinical leadership positions. Dr. Sonis
has published extensively on the clinical, biological, and health
economic aspects of oral complications of cancer therapy. He is
the author of over 90 original publications, 30 reviews and chapters,
5 books and numerous abstracts. Dr. Sonis has served on a number
of editorial boards. He is a founding member of the International
Society of Oral Oncology.
|